The American Journal of Medicine
Volume 123, Issue 9 , Pages 847-855 , September 2010

Management and Outcomes of Renal Disease and Acute Myocardial Infarction

  • Paul A. Santolucito, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Dennis A. Tighe, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • David D. McManus, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Jorge Yarzebski, MD, MPH

      Affiliations

    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Darleen Lessard, MS

      Affiliations

    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Joel M. Gore, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • ,
  • Robert J. Goldberg, PhD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
    • Corresponding Author InformationRequests for reprints should be addressed to Robert J. Goldberg, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655

References 

  1. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62:997–1004
  2. Fried LF, Shlipak MG, Crump C, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol. 2003;41:1364–1372
  3. Smith GL, Masoudi FA, Shlipak MG, et al. Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol. 2008;19:141–150
  4. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563–570
  5. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827–830
  6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). www.acc.org/clinical/guidelines/stemi/index.pdf2004;Accessed January 29, 2010
  7. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002;324:71–86
  8. Freemantle N, Cleland J, Young P, et al. Beta-blockade after myocardial infarction: systematic review and meta regression analysis. Br Med J. 1999;318:1730–1737
  9. Afilalo J, Majdan AA, Eisenberg MJ. Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials. Heart. 2007;93:914–921
  10. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction (Systematic overview of individual data from 100 000 patients in randomized trials). Circulation. 1998;97:2202–2212
  11. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006;296:1377–1384
  12. Menon V, Sarnak MJ, Lessard D, Goldberg RJ. Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease. Am J Cardiol. 2004;94:1290–1293
  13. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003;42:201–208
  14. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis. 2000;35:1044–1051
  15. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42:1535–1543
  16. Beattie JN, Soman SS, Sandberg KR, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 2001;37:1191–1200
  17. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981) (The Worcester Heart Attack Study). JAMA. 1986;255:2774–2779
  18. Floyd KC, Yarzebski J, Spencer FA, et al. A 30 year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009;2:88–95
  19. Levey AS, Bosch JP, Lewis JB, et al. Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–470
  20. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266
  21. McCullough PA, Li S, Jurkovitz CT, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(4 Suppl 2):S38–S45
  22. McCullough PA, Li S, Jurkovitz CT, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008;156:277–283
  23. Tessone A, Gottlieb S, Barbash IM, et al. Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology. 2007;108:193–199
  24. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107:87–92
  25. Sarnak MJ, Levy AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35(Suppl 4):S117–S131

 Funding:National Institutes of Health (RO1 HL35434).

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00462-6

doi: 10.1016/j.amjmed.2010.04.025

The American Journal of Medicine
Volume 123, Issue 9 , Pages 847-855 , September 2010

Article Tools

* Image Usage & Resolution